SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about allotment of ESOP

19 Sep 2022 Evaluate

Jagsonpal Pharmaceuticals has informed that the Nomination and Remuneration Committee today approved the grant of 10,47,920 employee stock options under the company’s Employees Stock Option Plan, 2022 at an exercise price of Rs 235 per option. The said options, which are convertible into equivalent number of equity shares of Rs 5.00 each, will vest in 4 equal annual tranches commencing from the first anniversary of the grant.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

192.80 -0.85 (-0.44%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×